litlas
ログインアカウント作成

Peter K. Kaiser

1982–2025 年に発表

129
論文数
30,742
被引用数
77
h 指数
125
i10 指数

被引用数

Peter K. Kaiser の年別被引用数1952 年: 被引用 1 件1965 年: 被引用 3 件1972 年: 被引用 1 件1986 年: 被引用 2 件1987 年: 被引用 2 件1988 年: 被引用 2 件1989 年: 被引用 3 件1990 年: 被引用 11 件1991 年: 被引用 26 件1992 年: 被引用 41 件1993 年: 被引用 38 件1994 年: 被引用 35 件1995 年: 被引用 31 件1996 年: 被引用 24 件1997 年: 被引用 12 件1998 年: 被引用 29 件1999 年: 被引用 29 件2000 年: 被引用 23 件2001 年: 被引用 18 件2002 年: 被引用 29 件2003 年: 被引用 17 件2004 年: 被引用 28 件2005 年: 被引用 52 件2006 年: 被引用 66 件2007 年: 被引用 147 件2008 年: 被引用 186 件2009 年: 被引用 167 件2010 年: 被引用 214 件2011 年: 被引用 194 件2012 年: 被引用 218 件2013 年: 被引用 235 件2014 年: 被引用 245 件2015 年: 被引用 250 件2016 年: 被引用 191 件2017 年: 被引用 192 件2018 年: 被引用 159 件2019 年: 被引用 633 件2020 年: 被引用 645 件2021 年: 被引用 683 件2022 年: 被引用 451 件2023 年: 被引用 396 件2024 年: 被引用 754 件2025 年: 被引用 330 件2026 年: 被引用 6 件1953〜1964 年は被引用が無いため表示していません1966〜1971 年は被引用が無いため表示していません1973〜1985 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 1,855 件、この内訳の 27.5%イギリス: 引用元論文 535 件、この内訳の 7.9%ドイツ: 引用元論文 407 件、この内訳の 6%中国: 引用元論文 384 件、この内訳の 5.7%イタリア: 引用元論文 297 件、この内訳の 4.4%日本: 引用元論文 296 件、この内訳の 4.4%オーストラリア: 引用元論文 282 件、この内訳の 4.2%スイス: 引用元論文 271 件、この内訳の 4%カナダ: 引用元論文 222 件、この内訳の 3.3%フランス: 引用元論文 220 件、この内訳の 3.3%インド: 引用元論文 165 件、この内訳の 2.4%韓国: 引用元論文 139 件、この内訳の 2.1%
0%27.5%その他 24.8%

機関

分野

  • Medicine75.6%
  • Biochemistry, Genetics and Molecular Biology10.4%
  • Immunology and Microbiology4.4%
  • Engineering3.7%
  • Neuroscience3.3%
  • Pharmacology, Toxicology and Pharmaceutics0.6%
  • その他2%

トピック

  • Retinal Diseases and Treatments21.2%
  • Retinal Imaging and Analysis8.6%
  • Ocular Diseases and Behçet’s Syndrome6.8%
  • Ophthalmology and Visual Impairment Studies5.9%
  • Retinal and Macular Surgery4.8%
  • Retinal and Optic Conditions3.9%
  • その他48.8%

共著者

全論文

検索で開く
  1. Ranibizumab for Neovascular Age-Related Macular Degeneration

    著者: Philip J. Rosenfeld, David M. Brown, Jeffrey S. Heier, David S. Boyer, Peter K. Kaiser, Carol Chung, Robert Y. Kim - New England Journal of Medicine 2006 被引用: 5,866

  2. Intravitreal Aflibercept (VEGF Trap-Eye) in Wet Age-related Macular Degeneration

    著者: Jeffrey S. Heier, David M. Brown, Victor Chong, Jean‐François Korobelnik, Peter K. Kaiser, Quan Dong Nguyen, Bernd Kirchhof, Allen C. Ho, Yuichiro Ogura, George D. Yancopoulos, Neil Stahl, Robert Vitti, Alyson J. Berliner, Yuhwen Soo, Majid Anderesi, Georg Groetzbach, Bernd Sommerauer, Rupert Sandbrink, Christian Simader, Ursula Schmidt‐Erfurth - Ophthalmology 2012 被引用: 2,470

  3. Efficacy and safety of avacincaptad pegol in patients with geographic atrophy (GATHER2): 12-month results from a randomised, double-masked, phase 3 trial

    著者: Arshad M. Khanani, Sunil Patel, Giovanni Staurenghi, Ramin Tadayoni, Carl J. Danzig, David Eichenbaum, Jason Hsu, Charles C. Wykoff, Jeffrey S. Heier, David R. Lally, Jordi Monés, Jared S. Nielsen, Veeral Sheth, Peter K. Kaiser, Julie Clark, Liansheng Zhu, Hersh Patel, Justin Tang, Dhaval Desai, Glenn J. Jaffe, Arturo Alezzandrini, A Francone, Joaquín Bafalluy, Silvina Bainttein, Silvina Bainttein, Mario Saravia, Matko Vidosevich, Carlos Zeolite, Federico Furno Sola, Andrew Chang, Elisa E. Cornish, Thanh N. Nguyen, Oliver Findl, Anton Haas, Martina Kralinger, Stefan Sacu, Laurence Postelmans, Michel Eid Farah, Maurício Maia, Márcio Bittar Nehemy, Fareed Ali, Michael H. Brent, Michael Dollin, John R. Gonder, Amin Kherani, Andrew Merkur, Raman Tuli, Monica Marie Lopera, Francisco J. Rodríguez, Mario Bradvica, Jan Ernest, Kuldar Kalijurand, Kai Noor, Yves Cohen, Catherine Creuzot‐Garcher, F. De Bats, François Devin, Catherine Français-Maury, Laurent Kodjikian, Jean François Korobelnik, Y. Le Mer, M. Quaranta El Maftouhi, Sam Razavi, Eric H. Souied, Ramin Tadayoni, Michel Weber, Nicole Eter, Nicolas Feltgen, Salvatore Grisanti, Peter Walter, Raffael Liegl, Katrin Lorenz, Georg Spital, Siegfried Priglinger, Martin S. Spitzer, Michael Völker, Tim U. Krohne, Claudia Jochmann, Chris P. Lohmann, Carsten Framme, Ágnes Kerényi, András Papp, András Seres, Edit Tóth‐Molnár, Alexis Tsorbatzoglou, A VAJAS, Balázs Varsányi, Gábor Vogt, Asaf Bar, Eva Eting, David Hauser, Jamie Levy, Nurit Mathalone, Haia Morori-Katz, Irit Rosenblatt, Shiri Soudry-Zayit, Omert Trivizky, Francesco Bandello, Antonio P. Ciardella, Michele Figus ほか 126 名 - The Lancet 2023 被引用: 315

  4. Ranibizumab versus Verteporfin for Neovascular Age-Related Macular Degeneration

    著者: David M. Brown, Peter K. Kaiser, Mark Michels, G. Soubrane, Jeffrey S. Heier, Robert Y. Kim, Judy P. Sy, Susan Schneider - New England Journal of Medicine 2006 被引用: 3,503

  5. Risk of Inflammation, Retinal Vasculitis, and Retinal Occlusion–Related Events with Brolucizumab

    著者: Jordi Monés, Sunil Srivastava, Glenn J. Jaffe, Ramin Tadayoni, Thomas A. Albini, Peter K. Kaiser, Frank G. Holz, Jean‐François Korobelnik, Ivana K. Kim, Christian Pruente, Timothy G. Murray, Jeffrey S. Heier - Ophthalmology 2020 被引用: 349

  6. Ranibizumab versus Verteporfin Photodynamic Therapy for Neovascular Age-Related Macular Degeneration: Two-Year Results of the ANCHOR Study

    著者: David M. Brown, Mark Michels, Peter K. Kaiser, Jeffrey S. Heier, Judy P. Sy, Tsontcho Ianchulev - Ophthalmology 2008 被引用: 1,316

  7. Review of gene therapies for age-related macular degeneration

    著者: Arshad M. Khanani, Mathew Thomas, Aamir Aziz, Christina Y. Weng, Carl J. Danzig, Glenn Yiu, Szilárd Kiss, Nadia K. Waheed, Peter K. Kaiser - Eye 2022 被引用: 115

  8. Intravitreal Aflibercept Injection for Neovascular Age-related Macular Degeneration

    著者: Ursula Schmidt‐Erfurth, Peter K. Kaiser, Jean‐François Korobelnik, David M. Brown, Victor Chong, Quan Dong Nguyen, Allen C. Ho, Yuichiro Ogura, Christian Simader, Glenn J. Jaffe, Jason S. Slakter, George D. Yancopoulos, Neil Stahl, Robert Vitti, Alyson J. Berliner, Yuhwen Soo, Majid Anderesi, Olaf Sowade, Oliver Zeitz, Christiane Norenberg, Rupert Sandbrink, Jeffrey S. Heier - Ophthalmology 2013 被引用: 811

  9. The International Vitreomacular Traction Study Group Classification of Vitreomacular Adhesion, Traction, and Macular Hole

    著者: Jay S. Duker, Peter K. Kaiser, Susanne Binder, Marc D. de Smet, Alain Gaudric, Elias Reichel, Srinivas Sadda, J. Sebag, Richard F. Spaide, Peter Stalmans - Ophthalmology 2013 被引用: 1,173

  10. Short-Term Outcomes of Faricimab in Patients with Neovascular Age-Related Macular Degeneration on Prior Anti-VEGF Therapy

    著者: Andrei-Alexandru Szigiato, Nitesh Mohan, Katherine E. Talcott, Danny A. Mammo, Amy Babiuch, Peter K. Kaiser, Justis P. Ehlers, Aleksandra Rachitskaya, Alex Yuan, Sunil K. Srivastava, Sumit Sharma - Ophthalmology Retina 2023 被引用: 63

  11. Intravitreal Aflibercept for Diabetic Macular Edema

    著者: Jean‐François Korobelnik, V. Diana, Ursula Schmidt‐Erfurth, David S. Boyer, Frank G. Holz, Jeffrey S. Heier, Edoardo Midena, Peter K. Kaiser, Hiroko Terasaki, Dennis M. Marcus, Quan Dong Nguyen, Glenn J. Jaffe, Jason S. Slakter, Christian Simader, Yuhwen Soo, Thomas Schmelter, George D. Yancopoulos, Neil Stahl, Robert Vitti, Alyson J. Berliner, Oliver Zeitz, Carola Metzig, David M. Brown - Ophthalmology 2014 被引用: 807

  12. Intravitreal Aflibercept for Diabetic Macular Edema

    著者: Jeffrey S. Heier, Jean‐François Korobelnik, David M. Brown, Ursula Schmidt‐Erfurth, V. Diana, Edoardo Midena, David S. Boyer, Hiroko Terasaki, Peter K. Kaiser, Dennis M. Marcus, Quan Dong Nguyen, Glenn J. Jaffe, Jason S. Slakter, Christian Simader, Yuhwen Soo, Thomas Schmelter, Robert Vitti, Alyson J. Berliner, Oliver Zeitz, Carola Metzig, Frank G. Holz - Ophthalmology 2016 被引用: 421

  13. Efficacy and Safety of Biosimilar FYB201 Compared with Ranibizumab in Neovascular Age-Related Macular Degeneration

    著者: Frank G. Holz, Piotr Oleksy, Federico Ricci, Peter K. Kaiser, Joachim Kiefer, Steffen Schmitz-Valckenberg - Ophthalmology 2021 被引用: 67

  14. Clinical impact of the worldwide shortage of verteporfin (Visudyne®) on ophthalmic care

    著者: Marc J. Sirks, Elon H. C. van Dijk, Noa Rosenberg, Carla E. M. Hollak, Stamatios Aslanis, Chui Ming Gemmy Cheung, Itay Chowers, Chiara M. Eandi, K. Bailey Freund, Frank G. Holz, Peter K. Kaiser, Andrew Lotery, Kyoko Ohno‐Matsui, Giuseppe Querques, Yousif Subhi, Ramin Tadayoni, Charles C. Wykoff, Dinah Zur, Roselie M.H. Diederen, Camiel J.F. Boon, Reinier O. Schlingemann - Acta Ophthalmologica 2022 被引用: 88

  15. RETINAL FLUID AND THICKNESS AS MEASURES OF DISEASE ACTIVITY IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION

    著者: Peter K. Kaiser, Charles C. Wykoff, Rishi P. Singh, Arshad M. Khanani, V. Diana, Hersh Patel, Nikhil Patel - Retina 2021 被引用: 72

  16. Pipeline therapies for neovascular age related macular degeneration

    著者: Sruthi Arepalli, Peter K. Kaiser - International Journal of Retina and Vitreous 2021 被引用: 42

  17. Safety Outcomes of Brolucizumab in Neovascular Age-Related Macular Degeneration

    著者: Arshad M. Khanani, Marco A. Zarbin, Mark Barakat, Thomas A. Albini, Peter K. Kaiser, B Guruprasad, Neetu Agashivala, Justin S. Yu, Charles C. Wykoff, Mathew W. MacCumber - JAMA Ophthalmology 2021 被引用: 114

  18. The 5 min meta-analysis: understanding how to read and interpret a forest plot

    著者: Yaping Chang, Mark Phillips, Robyn H. Guymer, Lehana Thabane, Mohit Bhandari, Varun Chaudhary, on behalf of the R.E.T.I.N.A. study group, Charles C. Wykoff, Sobha Sivaprasad, Peter K. Kaiser, David Sarraf, Sophie J. Bakri, Sunir J. Garg, Rishi P. Singh, Frank G. Holz, Tien Yin Wong - Eye 2022 被引用: 65

  19. Longitudinal Assessment of Ellipsoid Zone Integrity, Subretinal Hyperreflective Material, and Subretinal Pigment Epithelium Disease in Neovascular Age-Related Macular Degeneration

    著者: Justis P. Ehlers, Robert Zahid, Peter K. Kaiser, Jeffrey S. Heier, David M. Brown, Xiangyi Meng, Jamie Reese, Thuy Le, Leina Lunasco, Ming Hu, Sunil K. Srivastava - Ophthalmology Retina 2021 被引用: 65

  20. RNAi-Based Treatment for Neovascular Age-Related Macular Degeneration by Sirna-027

    著者: Peter K. Kaiser, R. C. Andrew Symons, Syed Mahmood Shah, Edward Quinlan, Homayoun Tabandeh, V. Diana, Gail Reisen, Jennifer A. Lockridge, Brian Short, Roberto Guerciolini, Quan Dong Nguyen - American Journal of Ophthalmology 2010 被引用: 193

  21. Tryptophan metabolism is a physiological integrator regulating circadian rhythms

    著者: Paul Petrus, Marlene Cervantes, Muntaha Samad, Tomoki Sato, Alina Chao, Shogo Sato, Kevin B. Koronowski, Grace Park, Yasmine Alam, Niklas Mejhert, Marcus Seldin, José Manuel Monroy Kuhn, Kenneth A. Dyar, Dominik Lutter, Pierre Baldi, Peter K. Kaiser, Cholsoon Jang, Paolo Sassone‐Corsi - Molecular Metabolism 2022 被引用: 51

  22. The DISCOVER Study 3-Year Results

    著者: Justis P. Ehlers, Yasha S. Modi, Paula E. Pecen, Jeffrey M. Goshe, William J. Dupps, Aleksandra Rachitskaya, Sumit Sharma, Alex Yuan, Rishi P. Singh, Peter K. Kaiser, Jamie Reese, Carmen Calabrise, Allison Watts, Sunil K. Srivastava - Ophthalmology 2018 被引用: 137

  23. Higher-Order Assessment of OCT in Diabetic Macular Edema from the VISTA Study: Ellipsoid Zone Dynamics and the Retinal Fluid Index

    著者: Justis P. Ehlers, Atsuro Uchida, Ming Hu, Natália Figueiredo, Peter K. Kaiser, Jeffrey S. Heier, David M. Brown, David S. Boyer, V. Diana, Andrea Gibson, Namrata Saroj, Sunil K. Srivastava - Ophthalmology Retina 2019 被引用: 72

  24. ANTI–VASCULAR ENDOTHELIAL GROWTH FACTOR BIOSIMILARS IN OPHTHALMOLOGY

    著者: Peter K. Kaiser, Marc Steffen Schmitz-Valckenberg, Frank G. Holz - Retina 2022 被引用: 52